Related Experiment Video
Updated: Mar 1, 2026

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
Blocking FSH induces thermogenic adipose tissue and reduces body fat
Peng Liu1, Yaoting Ji1,2, Tony Yuen1
1Department of Medicine, and Mount Sinai Bone Program, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA.
Abstract:
Menopause is associated with bone loss and enhanced visceral adiposity. A polyclonal antibody that targets the β-subunit of the pituitary hormone follicle-stimulating hormone (Fsh) increases bone mass in mice. Here, we report that this antibody sharply reduces adipose tissue in wild-type mice, phenocopying genetic haploinsufficiency for the Fsh receptor gene Fshr. The antibody also causes profound beiging, increases cellular mitochondrial density, activates brown adipose tissue and enhances thermogenesis. These actions result from the specific binding of the antibody to the β-subunit of Fsh to block its action. Our studies uncover opportunities for simultaneously treating obesity and osteoporosis.
Insights
A new antibody targeting follicle-stimulating hormone (FSH) reduces fat tissue and increases bone mass in mice. This discovery offers potential treatments for both obesity and osteoporosis.
Area of Science:
- Endocrinology
- Metabolic research
- Bone biology
Background:
- Menopause is linked to bone loss and increased visceral fat.
- Follicle-stimulating hormone (FSH) plays a role in these postmenopausal changes.
Purpose of the Study:
- To investigate the effects of targeting the FSH β-subunit with a polyclonal antibody.
- To explore potential therapeutic strategies for obesity and osteoporosis.
Main Methods:
- Administration of a polyclonal antibody targeting the FSH β-subunit in wild-type mice.
- Analysis of adipose tissue, bone mass, and brown adipose tissue activation.
- Comparison with genetic haploinsufficiency for the FSH receptor (Fshr).
Main Results:
- The FSH β-subunit antibody significantly reduced adipose tissue in mice.
- The antibody treatment mimicked the effects of Fshr gene haploinsufficiency.
- Enhanced browning of adipose tissue, increased mitochondrial density, and activated thermogenesis were observed.
- Increased bone mass was also noted, similar to previous findings.
Conclusions:
- Targeting the FSH β-subunit with a specific antibody can reduce fat accumulation and increase bone mass.
- This approach shows promise for simultaneously treating obesity and osteoporosis.
- Blocking FSH action presents a novel therapeutic avenue for metabolic and bone health.
Related Concept Videos
Thermoregulation
Hypodermis
Metabolic States of the Body: Fasting and Starvation
Decreased Body Temperature
Metabolic States of the Body: The Postabsorptive State
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...

